Julia Talsma, Content Channel Director
Julia Talsma is lead editor for Drug Topics magazine.
Denver to host the 2015 NACDS Total Store Expo in August
The event takes place August 22-25 at Denver's Colorado Convention Center, and the exhibit floor is nearly sold out.
Collaborative practice gains
Collaborative practice gains
Retail pharmacists are ideally situated to perform MTM through collaborative agreements with physicians, and some are making it happen.
FDA warns against use of certain closed system transfer devices with Treanda Injection
If the CSTDs contain ABS, there is risk of leakage and failure of the devices, and possible product contamination.
Sam’s Club provides greater savings on generic drugs
Sam’s Club is offering greater discounts and some free generic medications with an expanded prescription program for its Plus and Business Plus members.
Technology use in hospital pharmacy increases
Approximately one third of U.S. hospitals have completely migrated to the electronic health record (EHR) and are no longer using paper charts. In those hospitals with an EHR that they use completely or in combination with paper charts, 80% give pharmacists the ability to make recommendations and document them in the EHR.
Chronic pain meds misused by 20% to 25% of patients
Approximately 20 to 25 percent of patients using opioids for chronic pain have misused these drugs, according to a report published in the journal Pain.
New publication for pharmacy residents to debut in June
The mission of this peer-reviewed journal is to offer a forum for pharmacists to share their research and quality improvement projects from their residency training in an effort to advance patient care and optimize medication use.
Target Canada to close by April 12
Target Canada Co. announced that it will close all its 133 Canadian retail locations on April 12, completing its inventory liquidation, according to a company statement.
How to combat the Top 10 vaccine errors
The Institute for Safe Medication Practices has identified factors contributing to the top 10 vaccine-related errors and released a report with recommendations to combat these errors.
BioCryst receives $12 million for Ebola drug development
BioCryst Pharmaceuticals, Durham, North Carolina, was awarded a $12 million contract with the U.S. Department of Health and Human Services for the development and manufacture of its small molecule, BCX4430, for the prevention of Ebola virus reproduction.